Chronic Kidney Disease News

Romosozumab improved bone mineral density at the lumbar spine, total hip and femoral neck, and reduced the relative risk for fractures in women with osteoporosis and mild-to-moderate chronic kidney disease, according to study data.

Experts across the cardiorenal metabolic specialties will again convene to present innovative research on the relationship between type 2 diabetes, CVD and renal disease, including controversial debates and panel discussions.

Using a prediction model and electronic health records from before the pandemic, researchers estimated the burden that COVID-19 would have on patients with chronic kidney disease in the United Kingdom.

Compared with patients who had urgent-start temporary hemodialysis, patients who underwent urgent-start peritoneal dialysis during the transition of kidney failure to chronic dialysis showed fewer complications up to 6 weeks after dialysis.

Among patients with autosomal dominant polycystic kidney disease, outcomes were strongly associated with race and ethnicity.

The FDA has approved AbbVie’s Skyrizi for the treatment of adults with moderately to severely active Crohn’s disease, according to a company press release.

A higher consumption of ultra-processed foods is independently associated with a higher risk for incident chronic kidney disease among the general population.

An assessment of the 25-year risk of end-stage kidney disease among living kidney donors revealed different risks for different groups of donors, according to data presented at the American Transplant Congress.

ATLANTA — Use of empagliflozin was associated with a nearly 40% reduced risk for nephrolithiasis among people with type 2 diabetes, according to data presented at ENDO 2022.

Among patients with focal segmental glomerulosclerosis, immunosuppressant therapy reduced proteinuria but showed no certain impact on kidney function.